Baker Bros. Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Baker Bros. Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-812,814	Closed	-$1.02M	–	94
2025 Q2	$1.02M	Hold	812,814	–	–	0.01%	82
2025 Q1	$878K	Hold	812,814	–	–	0.01%	81
2024 Q4	$1.63M	Hold	812,814	–	–	0.02%	85
2024 Q3	$3.5M	Sell	812,814 -1	-0%	-$5	0.04%	75
2024 Q2	$4.81M	Hold	812,815	–	–	0.06%	66
2024 Q1	$5.79M	Hold	812,815	–	–	0.07%	61
2023 Q4	$6.58M	Buy	812,815 +6,275	+0.8%	+$34.6K	0.07%	59
2023 Q3	$4.97M	Buy	806,540 +363,986	+82%	+$2.67M	0.03%	66
2023 Q2	$3.89M	Buy	442,554 +95,000	+27%	+$1.05M	0.02%	77
2023 Q1	$2.56M	Hold	347,554	–	–	0.01%	86
2022 Q4	$2.82M	Buy	347,554 +107,506	+45%	+$1.16M	0.02%	91
2022 Q3	$3.22M	Hold	240,048	–	–	0.02%	90
2022 Q2	$3.91M	Hold	240,048	–	–	0.02%	85
2022 Q1	$5.47M	Buy	240,048 +170,000	+243%	+$3.05M	0.03%	84
2021 Q4	$1.63M	Hold	70,048	–	–	0.01%	109
2021 Q3	$4.13M	Hold	70,048	–	–	0.02%	101
2021 Q2	$6.42M	Hold	70,048	–	–	0.03%	90
2021 Q1	$9.42M	Hold	70,048	–	–	0.04%	77
2020 Q4	$7.77M	Hold	70,048	–	–	0.03%	81
2020 Q3	$6.63M	Hold	70,048	–	–	0.03%	75
2020 Q2	$8.14M	Hold	70,048	–	–	0.04%	69
2020 Q1	$5.78M	Sell	70,048 -19,238	-22%	-$2.11M	0.04%	63
2019 Q4	$10.9M	Hold	89,286	–	–	0.06%	52
2019 Q3	$6.7M	Hold	89,286	–	–	0.05%	57
2019 Q2	$6.01M	Buy	+89,286	New	+$9.47M	0.04%	61

Other funds holding HOOK

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Baker Bros. Advisors's HOOK Position: Q3 2025 in Review

Baker Bros. Advisors sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 812,814 shares — an estimated $1.02M sold.

Baker Bros. Advisors first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $10.9M in Q4 2019. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

Baker Bros. Advisors reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
Baker Bros. Advisors sold 812,814 HOOKIPA Pharma shares in Q3 2025, an estimated $1.02M.
Baker Bros. Advisors first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
Baker Bros. Advisors's HOOKIPA Pharma position peaked at $10.9M in Q4 2019.
6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Baker Bros. Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.